These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature. Kesari MV, Gaopande VL, Joshi AR, Babanagare SV, Gogate BP, Khadilkar AV. Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647 [Abstract] [Full Text] [Related]
27. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma. Matsukita S, Nomoto M, Kitajima S, Tanaka S, Goto M, Irimura T, Kim YS, Sato E, Yonezawa S. Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022 [Abstract] [Full Text] [Related]
30. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. Zhang HK, Zhang QM, Zhao TH, Li YY, Yi YF. World J Gastroenterol; 2004 Oct 15; 10(20):3044-7. PubMed ID: 15378790 [Abstract] [Full Text] [Related]
32. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Lee HS, Lee HK, Kim HS, Yang HK, Kim YI, Kim WH. Cancer; 2001 Sep 15; 92(6):1427-34. PubMed ID: 11745219 [Abstract] [Full Text] [Related]
33. Expression of aberrant mucins in lobular carcinoma with histiocytoid feature of the breast. Kasashima S, Kawashima A, Zen Y, Ozaki S, Kobayashi M, Tsujibata A, Minato H. Virchows Arch; 2007 Apr 15; 450(4):397-403. PubMed ID: 17333267 [Abstract] [Full Text] [Related]